These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 8115784)
1. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Kosary CL Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis. Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800 [TBL] [Abstract][Full Text] [Related]
4. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471 [TBL] [Abstract][Full Text] [Related]
5. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK; Zhang HT; Sun YC; Wu LY Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912 [TBL] [Abstract][Full Text] [Related]
6. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy]. Ma R; Zhang H; Zou L; Qu Y Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610 [TBL] [Abstract][Full Text] [Related]
7. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Steiner E; Eicher O; Sagemüller J; Schmidt M; Pilch H; Tanner B; Hengstler JG; Hofmann M; Knapstein PG Int J Gynecol Cancer; 2003; 13(2):197-203. PubMed ID: 12657124 [TBL] [Abstract][Full Text] [Related]
8. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Klint A; Tryggvadóttir L; Bray F; Gislum M; Hakulinen T; Storm HH; Engholm G Acta Oncol; 2010 Jun; 49(5):632-43. PubMed ID: 20307243 [TBL] [Abstract][Full Text] [Related]
10. Is there a revision needed of the current FIGO staging system? Menczer J Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1159-1161. PubMed ID: 28718876 [TBL] [Abstract][Full Text] [Related]
11. Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database. Ghezelayagh T; Rauh-Hain JA; Growdon WB Obstet Gynecol; 2015 Jun; 125(6):1353-1361. PubMed ID: 26000506 [TBL] [Abstract][Full Text] [Related]
12. Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study. Wu SG; Sun JY; He ZY; Chen QH; Zhou J J Gynecol Oncol; 2017 Nov; 28(6):e81. PubMed ID: 29027399 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines. Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324 [TBL] [Abstract][Full Text] [Related]
14. Survival benefit of vaginectomy compared to local tumor excision in women with FIGO stage I and II primary vaginal carcinoma: a SEER study. Zhou W; Yue Y; Pei D Arch Gynecol Obstet; 2020 Dec; 302(6):1429-1439. PubMed ID: 32780160 [TBL] [Abstract][Full Text] [Related]
15. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032 [TBL] [Abstract][Full Text] [Related]
16. Survival of gynecological cancers in Turkey: where are we at? Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma. Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258 [TBL] [Abstract][Full Text] [Related]
18. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659 [TBL] [Abstract][Full Text] [Related]
19. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma]. Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691 [TBL] [Abstract][Full Text] [Related]
20. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer]. Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063 [No Abstract] [Full Text] [Related] [Next] [New Search]